Fig. 2.

Change in fibrosis scores (F0–F1, F2, F3, and F4) in 42 patients with sustained virological response and assessed stage of fibrosis before treatment (baseline=0) and at follow-up. Nine patients were excluded because of missing paired data (n=7) or hepatocellular carcinoma (n=2).